MSc in Bacterial Physiology and PhD in Protein Biochemistry Professor (Associate) at Akdeniz University Structural and functional analysis of rat prolactin receptor gene. Rat prolactin receptor and isoforms in liver and kidney. Non-genotoxic toxicity and tumorigenesis mechanisms of ochratoxin A (OTA) in vivo and in vitro. The role of testosterone and estrogen in OTA toxicity. The receptor mediated OTA toxicity and tumorigenesis in rat kidney. Ochratoxins Prolactin Receptors Estrogen Antagonists Estrogen Receptor Testosterone Androgen Receptors Nonsteroidal Anti-Androgens Ovariectomy Castration mRNA Expression Renal Pathology Renal Cancer Targeted Drug Delivery Toxicity Endocrine Disruption Reproductive Toxicology Estrogens Cancer Biology Androgens Steroids Toxicity Studies Native PAGE Endocrine Disruptors Environmental Toxicology Animal Physiology Encapsulation Cancer Research Nanoparticles Microbiology Biotechnology Proteins Protein Stability Ions Mycotoxins Cancer Cell Biology Fluorescence Spectroscopy Site-Directed Mutagenesis Wistar Rats Protein Folding Circular Dichroism Protein Conformation Cell Culture Molecular Endocrinology Neuroendocrinology Biomarkers PCR Protein Purification Reproductive Endocrinology Protein Structure Protein-Protein Interaction
I am the Communications and Digital Platforms Associate at FEBS, and I help manage content and use of online platforms and sites such as the FEBS Network, FEBS website and FEBS Congress website, but particularly on the FEBS Network. Previously I have managed the funding programmes of a number of UK research charities, mainly in the field of cancer. I have supported the income generation teams at those organisations with science communication, as well as developed e-learning resources for staff and students at the Institute of Cancer Research. I have a BSc in Biochemistry, an MSc in Nutrition and a Postgraduate Diploma in Dietetics. After years in London I have now moved back to Spain, where I continue to work as a science communicator.
Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates, and member of the FEBS Network working group. She is currently the president of the SEBBM, a member of the FEBS Science and Society Committee and of the ISC Finances Committee.